Menstrual cycle dependent changes in blue-on-yellow visual field analysis of young diabetic women with severe non-proliferative diabetic retinopathy

Clinical and Experimental Ophthalmology

Volumn 32, Issue 3, 2004, Pages 265-269

  Apaydin, K Cemil ^a   Akar, Yusuf ^a   Akar, Murine Erman ^a   Zorlu, Gurkan C ^a   Ozer, Hilmi O ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Blue on yellow visual field; Diabetes; Follicular phase; Luteal phase; Menstrual cycle

Indexed keywords

ESTRADIOL; INSULIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONAL REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAOCULAR PRESSURE; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VISUAL ACUITY; VISUAL FIELD; BLOOD; METHODOLOGY; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PERIMETRY; PHYSIOLOGY; VISUAL DISORDER;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; PERIMETRY; PROGESTERONE; SENSORY THRESHOLDS; VISION DISORDERS; VISUAL FIELDS;

EID: 3142549147     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2004.00814.x     Document Type: Article

References (27)

1. Langham ME, Grebe R, Hopkins M et al. Choroidal blood flow in diabetic retinopathy. Exp Eye Res 1991; 52: 167-73.
2. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res 2002; 74: 615-25.
3. Kanski JJ. Diabetic retinopathy. In: Kanski JJ, ed. Clinical Ophthalmology. New York: Thieme, 1996; 330-63.
4. Greenstein VC, Hood DC, Ritch R, Steinberger D, Carr RE. S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci 1989; 30: 1732-7.
5. Nork TM, Wang LP, Poulson GL. Selective loss of photoreceptors in human diabetic retinopathy. Invest Ophthalmol Vis Sci 1994; 35: 1588.
6. Nomura R, Terasaki H, Hirose H, Miyake Y. Blue-on-yellow perimetry to evaluate S cone sensitivity in diabetics. Ophthalmic Res 2000; 32: 69-72.
7. Remky A, Arend O, Hendricks S. Short-wavelength automated perimetry and capillary density in early diabetic maculopathy. Invest Ophthalmol Vis Sci 2000; 41: 274-81.
8. Sample PA, Weinreb RN. Color perimetry for assessment of primary open angle glaucoma. Invest Ophthalmol Vis Sci 1990; 31: 1869-75.
9. Afrashi F, Erakgun T, Kose S, Ardic K, Mentes J. Blue-on-yellow perimetry versus achromatic perimetry in type 1 diabetes patients without retinopathy. Diabetes Res Clin Pract 2003; 61: 7-11.
10. Moberg E, Kollind M, Lins PE, Adamson U. Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle. Diabet Med 1995; 12: 224-8.
11. Zumoff B, Miller L, Poretsky L et al. Subnormal follicular-phase serum progesterone levels and elevated follicular-phase serum oestradiol levels in young women with insulin-dependent diabetes. Steroids 1990; 55: 560-64.
12. Lovestam-Adrian M, Agardh CD, Torffvit O, Agardh E. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation. Acta Ophthalmol Scand 2003; 81: 221-5.
13. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol 1998; 82: 862-70.
14. Heijl A, Lindgren G, Olsson J. The effect of perimetric experience in normal subjects. Arch Ophthalmol 1989; 107: 81-6.
15. Lobefalo L, Verrotti A, Mastropasqua L. Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy. Diabetes Care 1998; 21: 2003-6.
16. Schroeder B, Hertweck SP, Sanfilippo JS, Foster MB. Correlation between glycemic control and menstruation in diabetic adolescents. J Reprod Med 2000; 45: 1-5.
17. Distiller LA, Sagel J, Morley JE, Seftel HC. Pituitary responsiveness to luteinizing hormone-releasing hormone in insulin-dependent diabetes mellitus. Diabetes 1975; 24: 378-80.
18. Greenstein VC, Sarter B, Hood D, Noble K, Carr R. Hue discrimination and S cone sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1990; 31: 1008-14.
19. Greenstein VC, Shapiro A, Zaidi Q, Hood DC. Psychophysical evidence for post-receptoral sensitivity loss in diabetics. Invest Ophthalmol Vis Sci 1992; 33: 2781-90.
20. Taylor E, Dobree JH. Proliferative diabetic retinopathy. Site and size of initial lesions. Br J Ophthalmol 1970; 54: 11-18.
21. Nomura R, Terasaki H, Hirose H, Miyake Y. Blue-on-yellow perimetry to evaluate S cone sensitivity in diabetics. Ophthalmic Res 2000; 32: 69-72.
22. Magness RR, Rosenfeld CR. Local and systemic oestradiol-17 beta: effects on uterine and systemic vasodilatation. Am J Physiol 1989; 256: 536-42.
23. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990; 590: 287-98.
24. Brodde OE. Beta adrenoceptors. In: Williams M, Glennon RA, Timmermans PB, eds. Receptor Pharmacology and Function. New York. Marcel Dekker, 1989; 207-55.
25. Jing ZY, Towler HMA, Luthert P et al. Pathophysiology of diabetic retinopathy. In: LeRoith D, Taylor SL Olefsky JM, eds. Diabetes Mellitus. New York: Lippincott-Raven, 1996; 719-37.
26. Skovborg F, Nielsen AV, Lauritzen E et al. Diameters of the retinal vessels in diabetic and normal subjects. Diabetes 1969; 18: 292-8.
27. Kjaer K, Hagen C, Sando S, Eshoj O. Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to control subjects. J Clin Endocrinol Metab 1992; 75: 524-9.